44 13. Tosi LL, Floor MK, Dollar CM, et al. Assessing disease experienceacross the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study. Orphanet J Rare Dis. 2019;14(1):23. 14. Widmann RF, Bitan FD, Laplaza FJ, Burke SW, DiMaio MF, Schneider R.Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta. Spine (Phila Pa 1976). 1999;24(16):1673–8. 15. Widmann RF, Laplaza FJ, Bitan FD, Brooks CE, Root L. Quality of life inosteogenesis imperfecta. Int Orthop. 2002;26(1):3–6. 16. Forestier-Zhang L, Watts L, Turner A, et al. Health-related quality oflife and a cost-utility simulation of adults in the UKwith osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet J Rare Dis. 2016;11(1):1–9. 17. Balkefors V, Mattsson E, Pernow Y, Sääf M. Functioning and quality oflife in adults with mild-to-moderate osteogenesis imperfecta. Physiother Res Int. 2013;18(4):203–11. 18. Hald JD, Folkestad L, Harsløf T, Brixen K, Langdahl B. Health-relatedquality of life in adults with osteogenesis imperfecta. Calcif Tissue Int. 2017;101(5):473–8. 19. Handisides JC, Hollenbeck-Pringle D, Uzark K, et al. Health-relatedquality of life in children and young adults with Marfan syndrome. J Pediatr. 2018;204:250–5.e1. 20. Idorn L, Jensen AS, Juul K, et al. Quality of life and cognitive functionin Fontan patients, a population-based study. Int J Cardiol. 2013;168 (4):3230–5. 21. Dahan-Oliel N, Oliel S, Tsimicalis A, Montpetit K, Rauch F, Dogba MJ.Quality of life in osteogenesis imperfecta: a mixed-methods systematic review. Am J Med Genet Part A. 2016;170(1):62–76. 22. Nghiem T, Louli J, Treherne SC, et al. Pain experiences of children andadolescents with osteogenesis imperfecta: an integrative review. Clin J Pain. 2017 Mar;33(3):271–80. 23. Nicolaou N, Bowe JD, Wilkinson JM, Fernandes JA, Bell MJ. Use of theSheffield telescopic intramedullary rod system for the management of osteogenesis imperfecta: clinical outcomes at an average followup of nineteen years. J Bone Joint Surg Ser A. 2011;93(21):1994–2000. 24. Ablon J. Personality and stereotype in osteogenesis imperfecta: behavioral phenotype or response to life’s hard challenges? Am J Med Genet. 2003;122A(3):201–14. 25. Wiggins S, Kreikemeier R. Bisphosphonate therapy and osteogenesisimperfecta: the lived experience of children and their mothers. J Spec Pediatr Nurs. 2017;22:e12192. 26. Arabaci LB, Bozkurt S, Vara S, Ozen S, Darcan S, Simsek DG. Difficulties experienced by caregivers of patients diagnosed with osteogenesisimperfecta (OI): example of a hospital. J Pak Med Assoc. 2015;65(7):764–70.
RkJQdWJsaXNoZXIy MTk4NDMw